Primary |
Attention Deficit/hyperactivity Disorder |
85.4% |
Depression |
2.6% |
Anxiety |
1.6% |
Sleep Disorder |
1.3% |
Product Used For Unknown Indication |
1.2% |
Asthma |
0.8% |
Disturbance In Attention |
0.7% |
Insomnia |
0.7% |
Pain |
0.7% |
Psychomotor Hyperactivity |
0.7% |
Epilepsy |
0.7% |
Tourette's Disorder |
0.7% |
Bipolar I Disorder |
0.5% |
Abnormal Behaviour |
0.5% |
Tic |
0.4% |
Bipolar Disorder |
0.3% |
Asperger's Disorder |
0.3% |
Constipation |
0.3% |
Migraine |
0.3% |
Oppositional Defiant Disorder |
0.3% |
|
Suicidal Ideation |
23.3% |
Suicide Attempt |
9.7% |
Vomiting |
8.6% |
Syncope |
7.7% |
Weight Decreased |
7.2% |
Tachycardia |
6.0% |
Electrocardiogram Qt Prolonged |
5.6% |
Tic |
4.0% |
Weight Increased |
3.5% |
Completed Suicide |
2.6% |
Epilepsy |
2.4% |
Loss Of Consciousness |
2.4% |
Nausea |
2.4% |
Somnolence |
2.4% |
Death |
2.1% |
Prescribed Overdose |
2.1% |
Psychotic Disorder |
2.1% |
Hypertension |
2.0% |
Jaundice |
2.0% |
Overdose |
2.0% |
|
Secondary |
Attention Deficit/hyperactivity Disorder |
70.7% |
Depression |
5.3% |
Sleep Disorder |
3.6% |
Product Used For Unknown Indication |
3.2% |
Anxiety |
2.7% |
Drug Use For Unknown Indication |
2.2% |
Epilepsy |
1.6% |
Insomnia |
1.3% |
Bipolar Disorder |
1.3% |
Tourette's Disorder |
1.1% |
Asthma |
1.0% |
Bipolar I Disorder |
0.9% |
Tic |
0.9% |
Agitation |
0.8% |
Major Depression |
0.7% |
Psychomotor Hyperactivity |
0.7% |
Generalised Anxiety Disorder |
0.7% |
Disturbance In Attention |
0.6% |
Constipation |
0.5% |
Migraine |
0.5% |
|
Suicidal Ideation |
18.6% |
Weight Decreased |
10.6% |
Vomiting |
8.8% |
Suicide Attempt |
7.8% |
Syncope |
7.2% |
Tachycardia |
7.2% |
Tic |
5.6% |
Weight Increased |
5.4% |
Electrocardiogram Qt Prolonged |
4.8% |
Headache |
2.6% |
Sinus Tachycardia |
2.6% |
Nausea |
2.5% |
Panic Attack |
2.4% |
Somnolence |
2.4% |
Impulsive Behaviour |
2.1% |
Loss Of Consciousness |
2.0% |
Off Label Use |
2.0% |
Tremor |
2.0% |
Fatigue |
1.9% |
Aspartate Aminotransferase Increased |
1.7% |
|
Concomitant |
Attention Deficit/hyperactivity Disorder |
23.2% |
Product Used For Unknown Indication |
17.2% |
Depression |
11.9% |
Bipolar Disorder |
7.6% |
Anxiety |
6.0% |
Drug Use For Unknown Indication |
6.0% |
Pain |
2.9% |
Insomnia |
2.7% |
Contraception |
2.6% |
Asthma |
2.1% |
Crohn's Disease |
2.1% |
Hypertension |
2.1% |
Restless Legs Syndrome |
2.0% |
Premenstrual Syndrome |
1.8% |
Smoking Cessation Therapy |
1.8% |
Gastrooesophageal Reflux Disease |
1.7% |
Migraine |
1.6% |
Obsessive-compulsive Disorder |
1.6% |
Affective Disorder |
1.5% |
Mental Disorder |
1.5% |
|
Weight Increased |
19.9% |
Weight Decreased |
6.6% |
Nausea |
6.4% |
Vomiting |
6.1% |
Drug Ineffective |
5.8% |
No Adverse Event |
5.8% |
Rash |
5.2% |
Somnolence |
5.2% |
Product Quality Issue |
4.4% |
Off Label Use |
3.9% |
Insomnia |
3.6% |
Syncope |
3.6% |
Pulmonary Embolism |
3.3% |
Headache |
3.0% |
Suicidal Ideation |
3.0% |
Tremor |
3.0% |
Pancreatitis |
2.8% |
Paraesthesia |
2.8% |
Tardive Dyskinesia |
2.8% |
Tic |
2.8% |
|
Interacting |
Attention Deficit/hyperactivity Disorder |
35.9% |
Product Used For Unknown Indication |
7.8% |
Restless Legs Syndrome |
6.0% |
Migraine |
5.4% |
Rapid Eye Movements Sleep Abnormal |
5.4% |
Bipolar Disorder |
3.6% |
Depression |
3.6% |
Tic |
3.6% |
Autoimmune Thyroiditis |
3.0% |
Disturbance In Attention |
3.0% |
Gastrooesophageal Reflux Disease |
3.0% |
Memory Impairment |
3.0% |
Osteoporosis |
3.0% |
Parkinson's Disease |
3.0% |
Smoking Cessation Therapy |
3.0% |
Hormone Therapy |
2.4% |
Drug Use For Unknown Indication |
1.8% |
Abnormal Behaviour |
1.2% |
Arthritis |
1.2% |
Inflammation |
1.2% |
|
Drug Interaction |
21.7% |
Syncope |
17.4% |
Tourette's Disorder |
17.4% |
Suicidal Ideation |
11.6% |
Muscle Contractions Involuntary |
7.2% |
Performance Status Decreased |
4.3% |
Tremor |
4.3% |
Speech Disorder |
2.9% |
Chest Pain |
1.4% |
Nausea |
1.4% |
Oedema Peripheral |
1.4% |
Psychotic Disorder |
1.4% |
Road Traffic Accident |
1.4% |
Sinus Tachycardia |
1.4% |
Vertigo |
1.4% |
Weight Abnormal |
1.4% |
Weight Decreased |
1.4% |
|